CSPC Pharmaceutical Group Limited
CSPCY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $4,605 | $7,389 | $6,091 | $6,847 |
| Dep. & Amort. | $1,339 | $1,117 | $1,048 | $865 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $210 | $259 | $141 | $18 |
| Change in WC | -$206 | -$2,746 | $352 | -$1,988 |
| Other Non-Cash | -$1,415 | -$1,841 | -$5 | -$1,106 |
| Operating Cash Flow | $4,535 | $4,179 | $7,627 | $4,637 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,119 | -$1,786 | -$2,513 | -$1,419 |
| Net Acquisitions | -$173 | $0 | -$387 | $40 |
| Inv. Purchases | -$4,410 | -$4,721 | -$7,283 | -$6,513 |
| Inv. Sales/Matur. | $2,968 | $6,749 | $3,419 | $7,273 |
| Other Inv. Act. | -$124 | $366 | -$32 | -$18 |
| Investing Cash Flow | -$3,858 | $607 | -$6,796 | -$637 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $19 | -$28 | -$10 | -$99 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$2,336 | -$200 | -$14 | -$264 |
| Dividends Paid | -$3,441 | -$2,999 | -$2,097 | -$2,074 |
| Other Fin. Act. | $505 | $926 | $217 | $240 |
| Financing Cash Flow | -$5,253 | -$2,301 | -$1,904 | -$2,197 |
| Forex Effect | $3 | $4 | $16 | -$2 |
| Net Chg. in Cash | -$4,573 | $2,490 | -$1,059 | $1,800 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11,541 | $8,001 | $9,060 | $8,650 |
| End Cash | $6,297 | $10,491 | $8,001 | $11,115 |
| Free Cash Flow | $1,856 | $2,286 | $4,904 | $2,878 |